Multiplex lysosomal enzyme activity assay on dried blood spots using tandem mass spectrometry
- PMID: 20077085
- PMCID: PMC3442156
- DOI: 10.1007/978-1-60761-459-3_32
Multiplex lysosomal enzyme activity assay on dried blood spots using tandem mass spectrometry
Abstract
Deficiencies in any of the 50 degradative enzymes found in lysosomes results in the accumulation of undegraded material and subsequently cellular dysfunction. Early identification of deficiencies before irreversible organ and tissue damages occur leads to better clinical outcomes. In the method which follows, lysosomal alpha-glucosidase, alpha-galactosidase, beta-glucocerebrosidase, acid sphingomyelinase, and galactocerebrosidase are extracted from dried blood spots and incubated individually with an enzyme-specific cocktail containing the corresponding substrate and internal standard. Each enzyme cocktail is prepared using commercially available mixture of substrate and internal standard at the predetermined optimized molar ratio. After incubation, the enzymatic reactions are quenched using an ethyl acetate/methanol solution and all five enzyme solutions are combined. The mixtures of the reaction products are prepared using liquid-liquid and solid-phase extractions and quantified simultaneously using selected ion monitoring on LC-MS-MS system.
Figures

References
-
- Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill; 2001.
-
- Meikle PJ, Hopwood JJ. Lysosomal storage disorders: emerging therapeutic options require early diagnosis. Eur J Pediatr. 2003;162:S34–S37. - PubMed
-
- Clarke LA. The mucopolysaccharidoses: a success of molecular medicine. Expert Rev Mol Med. 2008;10(1):e1. - PubMed
-
- Rohrbach M, Clarke JT. Treatment of lysosomal storage disorders: progress with enzyme replacement therapy. Drugs. 2007;67:2697–2716. - PubMed
-
- Chien Y-H, Chiang S-C, Zhang XK, Keutzer JM, Lee N-C, Huang A-C, Chen C-A, Wu M-H, Huang P-H, Tsai F-J, Chen Y-T, Hwu W-L. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Pediatrics. 2008;122:e39–e45. - PubMed